 | • レポートコード：QFJ1-4755 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、月経前症候群の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛薬（鎮痛剤）、経口避妊薬（OCP）、ゴナドトロピン放出ホルモン（GnRH）、抗うつ薬、卵巣抑制薬、利尿薬、ベンゾジアゼピン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・月経前症候群の市場動向 ・企業の競争状況、市場シェア ・月経前症候群の種類別市場規模と予測2016-2027（鎮痛薬（鎮痛剤）、経口避妊薬（OCP）、ゴナドトロピン放出ホルモン（GnRH）、抗うつ薬、卵巣抑制薬、利尿薬、ベンゾジアゼピン） ・月経前症候群の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・月経前症候群の北米市場規模2016-2027（アメリカ、カナダ） ・月経前症候群の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・月経前症候群のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・月経前症候群の中南米市場規模2016-2027（メキシコ、ブラジル） ・月経前症候群の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Alva-Amco Pharmacal Cos., Inc.、Bayer, Inc.、Chattem, Inc. (Sanofi)、DEKK-TEC, Inc.、G. R. Lane Health Products Ltd、McNeil Consumer Healthcare、MetP Pharma AG、Pherin Pharmaceuticals, Inc.、Umecrine Mood AB、Novartis AG、GlaxoSmithKline Plc） ・結論 |
Pre-menstrual syndrome (PMS) is defined as a condition that affects women at childbearing age and is characterized by symptoms such as bloating, pain, breast tenderness, body pain, fatigue, mood fluctuation, anxiety, etc.
Market Analysis and Insights: Global Pre-Menstrual Syndrome Market
The global Pre-Menstrual Syndrome market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pre-Menstrual Syndrome market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pre-Menstrual Syndrome market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pre-Menstrual Syndrome market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pre-Menstrual Syndrome market.
Global Pre-Menstrual Syndrome Scope and Market Size
Pre-Menstrual Syndrome market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pre-Menstrual Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Analgesics (Pain Killers)
Oral Contraceptive Pills (OCPs)
Gonadotropin-Releasing Hormone (GnRH)
Antidepressants
Ovarian Suppressors
Diuretics
Benzodiazepines
Segment by Application
Hospitals
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Alva-Amco Pharmacal Cos., Inc.
Bayer, Inc.
Chattem, Inc. (Sanofi)
DEKK-TEC, Inc.
G. R. Lane Health Products Ltd
McNeil Consumer Healthcare
MetP Pharma AG
Pherin Pharmaceuticals, Inc.
Umecrine Mood AB
Novartis AG
GlaxoSmithKline Plc
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pre-Menstrual Syndrome Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Analgesics (Pain Killers)
1.2.3 Oral Contraceptive Pills (OCPs)
1.2.4 Gonadotropin-Releasing Hormone (GnRH)
1.2.5 Antidepressants
1.2.6 Ovarian Suppressors
1.2.7 Diuretics
1.2.8 Benzodiazepines
1.3 Market by Application
1.3.1 Global Pre-Menstrual Syndrome Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pre-Menstrual Syndrome Market Perspective (2016-2027)
2.2 Pre-Menstrual Syndrome Growth Trends by Regions
2.2.1 Pre-Menstrual Syndrome Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pre-Menstrual Syndrome Historic Market Share by Regions (2016-2021)
2.2.3 Pre-Menstrual Syndrome Forecasted Market Size by Regions (2022-2027)
2.3 Pre-Menstrual Syndrome Industry Dynamic
2.3.1 Pre-Menstrual Syndrome Market Trends
2.3.2 Pre-Menstrual Syndrome Market Drivers
2.3.3 Pre-Menstrual Syndrome Market Challenges
2.3.4 Pre-Menstrual Syndrome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pre-Menstrual Syndrome Players by Revenue
3.1.1 Global Top Pre-Menstrual Syndrome Players by Revenue (2016-2021)
3.1.2 Global Pre-Menstrual Syndrome Revenue Market Share by Players (2016-2021)
3.2 Global Pre-Menstrual Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pre-Menstrual Syndrome Revenue
3.4 Global Pre-Menstrual Syndrome Market Concentration Ratio
3.4.1 Global Pre-Menstrual Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pre-Menstrual Syndrome Revenue in 2020
3.5 Pre-Menstrual Syndrome Key Players Head office and Area Served
3.6 Key Players Pre-Menstrual Syndrome Product Solution and Service
3.7 Date of Enter into Pre-Menstrual Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pre-Menstrual Syndrome Breakdown Data by Type
4.1 Global Pre-Menstrual Syndrome Historic Market Size by Type (2016-2021)
4.2 Global Pre-Menstrual Syndrome Forecasted Market Size by Type (2022-2027)
5 Pre-Menstrual Syndrome Breakdown Data by Application
5.1 Global Pre-Menstrual Syndrome Historic Market Size by Application (2016-2021)
5.2 Global Pre-Menstrual Syndrome Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pre-Menstrual Syndrome Market Size (2016-2027)
6.2 North America Pre-Menstrual Syndrome Market Size by Type
6.2.1 North America Pre-Menstrual Syndrome Market Size by Type (2016-2021)
6.2.2 North America Pre-Menstrual Syndrome Market Size by Type (2022-2027)
6.2.3 North America Pre-Menstrual Syndrome Market Size by Type (2016-2027)
6.3 North America Pre-Menstrual Syndrome Market Size by Application
6.3.1 North America Pre-Menstrual Syndrome Market Size by Application (2016-2021)
6.3.2 North America Pre-Menstrual Syndrome Market Size by Application (2022-2027)
6.3.3 North America Pre-Menstrual Syndrome Market Size by Application (2016-2027)
6.4 North America Pre-Menstrual Syndrome Market Size by Country
6.4.1 North America Pre-Menstrual Syndrome Market Size by Country (2016-2021)
6.4.2 North America Pre-Menstrual Syndrome Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Pre-Menstrual Syndrome Market Size (2016-2027)
7.2 Europe Pre-Menstrual Syndrome Market Size by Type
7.2.1 Europe Pre-Menstrual Syndrome Market Size by Type (2016-2021)
7.2.2 Europe Pre-Menstrual Syndrome Market Size by Type (2022-2027)
7.2.3 Europe Pre-Menstrual Syndrome Market Size by Type (2016-2027)
7.3 Europe Pre-Menstrual Syndrome Market Size by Application
7.3.1 Europe Pre-Menstrual Syndrome Market Size by Application (2016-2021)
7.3.2 Europe Pre-Menstrual Syndrome Market Size by Application (2022-2027)
7.3.3 Europe Pre-Menstrual Syndrome Market Size by Application (2016-2027)
7.4 Europe Pre-Menstrual Syndrome Market Size by Country
7.4.1 Europe Pre-Menstrual Syndrome Market Size by Country (2016-2021)
7.4.2 Europe Pre-Menstrual Syndrome Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pre-Menstrual Syndrome Market Size (2016-2027)
8.2 Asia-Pacific Pre-Menstrual Syndrome Market Size by Type
8.2.1 Asia-Pacific Pre-Menstrual Syndrome Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pre-Menstrual Syndrome Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pre-Menstrual Syndrome Market Size by Type (2016-2027)
8.3 Asia-Pacific Pre-Menstrual Syndrome Market Size by Application
8.3.1 Asia-Pacific Pre-Menstrual Syndrome Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pre-Menstrual Syndrome Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pre-Menstrual Syndrome Market Size by Application (2016-2027)
8.4 Asia-Pacific Pre-Menstrual Syndrome Market Size by Region
8.4.1 Asia-Pacific Pre-Menstrual Syndrome Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pre-Menstrual Syndrome Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pre-Menstrual Syndrome Market Size (2016-2027)
9.2 Latin America Pre-Menstrual Syndrome Market Size by Type
9.2.1 Latin America Pre-Menstrual Syndrome Market Size by Type (2016-2021)
9.2.2 Latin America Pre-Menstrual Syndrome Market Size by Type (2022-2027)
9.2.3 Latin America Pre-Menstrual Syndrome Market Size by Type (2016-2027)
9.3 Latin America Pre-Menstrual Syndrome Market Size by Application
9.3.1 Latin America Pre-Menstrual Syndrome Market Size by Application (2016-2021)
9.3.2 Latin America Pre-Menstrual Syndrome Market Size by Application (2022-2027)
9.3.3 Latin America Pre-Menstrual Syndrome Market Size by Application (2016-2027)
9.4 Latin America Pre-Menstrual Syndrome Market Size by Country
9.4.1 Latin America Pre-Menstrual Syndrome Market Size by Country (2016-2021)
9.4.2 Latin America Pre-Menstrual Syndrome Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pre-Menstrual Syndrome Market Size (2016-2027)
10.2 Middle East & Africa Pre-Menstrual Syndrome Market Size by Type
10.2.1 Middle East & Africa Pre-Menstrual Syndrome Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pre-Menstrual Syndrome Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pre-Menstrual Syndrome Market Size by Type (2016-2027)
10.3 Middle East & Africa Pre-Menstrual Syndrome Market Size by Application
10.3.1 Middle East & Africa Pre-Menstrual Syndrome Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pre-Menstrual Syndrome Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pre-Menstrual Syndrome Market Size by Application (2016-2027)
10.4 Middle East & Africa Pre-Menstrual Syndrome Market Size by Country
10.4.1 Middle East & Africa Pre-Menstrual Syndrome Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pre-Menstrual Syndrome Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Alva-Amco Pharmacal Cos., Inc.
11.1.1 Alva-Amco Pharmacal Cos., Inc. Company Details
11.1.2 Alva-Amco Pharmacal Cos., Inc. Business Overview
11.1.3 Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Introduction
11.1.4 Alva-Amco Pharmacal Cos., Inc. Revenue in Pre-Menstrual Syndrome Business (2016-2021)
11.1.5 Alva-Amco Pharmacal Cos., Inc. Recent Development
11.2 Bayer, Inc.
11.2.1 Bayer, Inc. Company Details
11.2.2 Bayer, Inc. Business Overview
11.2.3 Bayer, Inc. Pre-Menstrual Syndrome Introduction
11.2.4 Bayer, Inc. Revenue in Pre-Menstrual Syndrome Business (2016-2021)
11.2.5 Bayer, Inc. Recent Development
11.3 Chattem, Inc. (Sanofi)
11.3.1 Chattem, Inc. (Sanofi) Company Details
11.3.2 Chattem, Inc. (Sanofi) Business Overview
11.3.3 Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Introduction
11.3.4 Chattem, Inc. (Sanofi) Revenue in Pre-Menstrual Syndrome Business (2016-2021)
11.3.5 Chattem, Inc. (Sanofi) Recent Development
11.4 DEKK-TEC, Inc.
11.4.1 DEKK-TEC, Inc. Company Details
11.4.2 DEKK-TEC, Inc. Business Overview
11.4.3 DEKK-TEC, Inc. Pre-Menstrual Syndrome Introduction
11.4.4 DEKK-TEC, Inc. Revenue in Pre-Menstrual Syndrome Business (2016-2021)
11.4.5 DEKK-TEC, Inc. Recent Development
11.5 G. R. Lane Health Products Ltd
11.5.1 G. R. Lane Health Products Ltd Company Details
11.5.2 G. R. Lane Health Products Ltd Business Overview
11.5.3 G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Introduction
11.5.4 G. R. Lane Health Products Ltd Revenue in Pre-Menstrual Syndrome Business (2016-2021)
11.5.5 G. R. Lane Health Products Ltd Recent Development
11.6 McNeil Consumer Healthcare
11.6.1 McNeil Consumer Healthcare Company Details
11.6.2 McNeil Consumer Healthcare Business Overview
11.6.3 McNeil Consumer Healthcare Pre-Menstrual Syndrome Introduction
11.6.4 McNeil Consumer Healthcare Revenue in Pre-Menstrual Syndrome Business (2016-2021)
11.6.5 McNeil Consumer Healthcare Recent Development
11.7 MetP Pharma AG
11.7.1 MetP Pharma AG Company Details
11.7.2 MetP Pharma AG Business Overview
11.7.3 MetP Pharma AG Pre-Menstrual Syndrome Introduction
11.7.4 MetP Pharma AG Revenue in Pre-Menstrual Syndrome Business (2016-2021)
11.7.5 MetP Pharma AG Recent Development
11.8 Pherin Pharmaceuticals, Inc.
11.8.1 Pherin Pharmaceuticals, Inc. Company Details
11.8.2 Pherin Pharmaceuticals, Inc. Business Overview
11.8.3 Pherin Pharmaceuticals, Inc. Pre-Menstrual Syndrome Introduction
11.8.4 Pherin Pharmaceuticals, Inc. Revenue in Pre-Menstrual Syndrome Business (2016-2021)
11.8.5 Pherin Pharmaceuticals, Inc. Recent Development
11.9 Umecrine Mood AB
11.9.1 Umecrine Mood AB Company Details
11.9.2 Umecrine Mood AB Business Overview
11.9.3 Umecrine Mood AB Pre-Menstrual Syndrome Introduction
11.9.4 Umecrine Mood AB Revenue in Pre-Menstrual Syndrome Business (2016-2021)
11.9.5 Umecrine Mood AB Recent Development
11.10 Novartis AG
11.10.1 Novartis AG Company Details
11.10.2 Novartis AG Business Overview
11.10.3 Novartis AG Pre-Menstrual Syndrome Introduction
11.10.4 Novartis AG Revenue in Pre-Menstrual Syndrome Business (2016-2021)
11.10.5 Novartis AG Recent Development
11.11 GlaxoSmithKline Plc
11.11.1 GlaxoSmithKline Plc Company Details
11.11.2 GlaxoSmithKline Plc Business Overview
11.11.3 GlaxoSmithKline Plc Pre-Menstrual Syndrome Introduction
11.11.4 GlaxoSmithKline Plc Revenue in Pre-Menstrual Syndrome Business (2016-2021)
11.11.5 GlaxoSmithKline Plc Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Pre-Menstrual Syndrome Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Analgesics (Pain Killers)
Table 3. Key Players of Oral Contraceptive Pills (OCPs)
Table 4. Key Players of Gonadotropin-Releasing Hormone (GnRH)
Table 5. Key Players of Antidepressants
Table 6. Key Players of Ovarian Suppressors
Table 7. Key Players of Diuretics
Table 8. Key Players of Benzodiazepines
Table 9. Global Pre-Menstrual Syndrome Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Pre-Menstrual Syndrome Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Pre-Menstrual Syndrome Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Pre-Menstrual Syndrome Market Share by Regions (2016-2021)
Table 13. Global Pre-Menstrual Syndrome Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Pre-Menstrual Syndrome Market Share by Regions (2022-2027)
Table 15. Pre-Menstrual Syndrome Market Trends
Table 16. Pre-Menstrual Syndrome Market Drivers
Table 17. Pre-Menstrual Syndrome Market Challenges
Table 18. Pre-Menstrual Syndrome Market Restraints
Table 19. Global Pre-Menstrual Syndrome Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Pre-Menstrual Syndrome Market Share by Players (2016-2021)
Table 21. Global Top Pre-Menstrual Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pre-Menstrual Syndrome as of 2020)
Table 22. Ranking of Global Top Pre-Menstrual Syndrome Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Pre-Menstrual Syndrome Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Pre-Menstrual Syndrome Product Solution and Service
Table 26. Date of Enter into Pre-Menstrual Syndrome Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Pre-Menstrual Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Pre-Menstrual Syndrome Revenue Market Share by Type (2016-2021)
Table 30. Global Pre-Menstrual Syndrome Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Pre-Menstrual Syndrome Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Pre-Menstrual Syndrome Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Pre-Menstrual Syndrome Revenue Market Share by Application (2016-2021)
Table 34. Global Pre-Menstrual Syndrome Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Pre-Menstrual Syndrome Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Pre-Menstrual Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Pre-Menstrual Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Pre-Menstrual Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Pre-Menstrual Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Pre-Menstrual Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Pre-Menstrual Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Pre-Menstrual Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Pre-Menstrual Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Pre-Menstrual Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Pre-Menstrual Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Pre-Menstrual Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Pre-Menstrual Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pre-Menstrual Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Pre-Menstrual Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Pre-Menstrual Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Pre-Menstrual Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Pre-Menstrual Syndrome Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Pre-Menstrual Syndrome Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Pre-Menstrual Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Pre-Menstrual Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Pre-Menstrual Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Pre-Menstrual Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Pre-Menstrual Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Pre-Menstrual Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pre-Menstrual Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Pre-Menstrual Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Pre-Menstrual Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Pre-Menstrual Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Pre-Menstrual Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Pre-Menstrual Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 66. Alva-Amco Pharmacal Cos., Inc. Company Details
Table 67. Alva-Amco Pharmacal Cos., Inc. Business Overview
Table 68. Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Product
Table 69. Alva-Amco Pharmacal Cos., Inc. Revenue in Pre-Menstrual Syndrome Business (2016-2021) & (US$ Million)
Table 70. Alva-Amco Pharmacal Cos., Inc. Recent Development
Table 71. Bayer, Inc. Company Details
Table 72. Bayer, Inc. Business Overview
Table 73. Bayer, Inc. Pre-Menstrual Syndrome Product
Table 74. Bayer, Inc. Revenue in Pre-Menstrual Syndrome Business (2016-2021) & (US$ Million)
Table 75. Bayer, Inc. Recent Development
Table 76. Chattem, Inc. (Sanofi) Company Details
Table 77. Chattem, Inc. (Sanofi) Business Overview
Table 78. Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Product
Table 79. Chattem, Inc. (Sanofi) Revenue in Pre-Menstrual Syndrome Business (2016-2021) & (US$ Million)
Table 80. Chattem, Inc. (Sanofi) Recent Development
Table 81. DEKK-TEC, Inc. Company Details
Table 82. DEKK-TEC, Inc. Business Overview
Table 83. DEKK-TEC, Inc. Pre-Menstrual Syndrome Product
Table 84. DEKK-TEC, Inc. Revenue in Pre-Menstrual Syndrome Business (2016-2021) & (US$ Million)
Table 85. DEKK-TEC, Inc. Recent Development
Table 86. G. R. Lane Health Products Ltd Company Details
Table 87. G. R. Lane Health Products Ltd Business Overview
Table 88. G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Product
Table 89. G. R. Lane Health Products Ltd Revenue in Pre-Menstrual Syndrome Business (2016-2021) & (US$ Million)
Table 90. G. R. Lane Health Products Ltd Recent Development
Table 91. McNeil Consumer Healthcare Company Details
Table 92. McNeil Consumer Healthcare Business Overview
Table 93. McNeil Consumer Healthcare Pre-Menstrual Syndrome Product
Table 94. McNeil Consumer Healthcare Revenue in Pre-Menstrual Syndrome Business (2016-2021) & (US$ Million)
Table 95. McNeil Consumer Healthcare Recent Development
Table 96. MetP Pharma AG Company Details
Table 97. MetP Pharma AG Business Overview
Table 98. MetP Pharma AG Pre-Menstrual Syndrome Product
Table 99. MetP Pharma AG Revenue in Pre-Menstrual Syndrome Business (2016-2021) & (US$ Million)
Table 100. MetP Pharma AG Recent Development
Table 101. Pherin Pharmaceuticals, Inc. Company Details
Table 102. Pherin Pharmaceuticals, Inc. Business Overview
Table 103. Pherin Pharmaceuticals, Inc. Revenue in Pre-Menstrual Syndrome Business (2016-2021) & (US$ Million)
Table 104. Pherin Pharmaceuticals, Inc. Recent Development
Table 105. Umecrine Mood AB Company Details
Table 106. Umecrine Mood AB Business Overview
Table 107. Umecrine Mood AB Pre-Menstrual Syndrome Product
Table 108. Umecrine Mood AB Revenue in Pre-Menstrual Syndrome Business (2016-2021) & (US$ Million)
Table 109. Umecrine Mood AB Recent Development
Table 110. Novartis AG Company Details
Table 111. Novartis AG Business Overview
Table 112. Novartis AG Pre-Menstrual Syndrome Product
Table 113. Novartis AG Revenue in Pre-Menstrual Syndrome Business (2016-2021) & (US$ Million)
Table 114. Novartis AG Recent Development
Table 115. GlaxoSmithKline Plc Company Details
Table 116. GlaxoSmithKline Plc Business Overview
Table 117. GlaxoSmithKline Plc Pre-Menstrual Syndrome Product
Table 118. GlaxoSmithKline Plc Revenue in Pre-Menstrual Syndrome Business (2016-2021) & (US$ Million)
Table 119. GlaxoSmithKline Plc Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pre-Menstrual Syndrome Market Share by Type: 2020 VS 2027
Figure 2. Analgesics (Pain Killers) Features
Figure 3. Oral Contraceptive Pills (OCPs) Features
Figure 4. Gonadotropin-Releasing Hormone (GnRH) Features
Figure 5. Antidepressants Features
Figure 6. Ovarian Suppressors Features
Figure 7. Diuretics Features
Figure 8. Benzodiazepines Features
Figure 9. Global Pre-Menstrual Syndrome Market Share by Application: 2020 VS 2027
Figure 10. Hospitals Case Studies
Figure 11. Clinic Case Studies
Figure 12. Others Case Studies
Figure 13. Pre-Menstrual Syndrome Report Years Considered
Figure 14. Global Pre-Menstrual Syndrome Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Pre-Menstrual Syndrome Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Pre-Menstrual Syndrome Market Share by Regions: 2020 VS 2027
Figure 17. Global Pre-Menstrual Syndrome Market Share by Regions (2022-2027)
Figure 18. Global Pre-Menstrual Syndrome Market Share by Players in 2020
Figure 19. Global Top Pre-Menstrual Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pre-Menstrual Syndrome as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Pre-Menstrual Syndrome Revenue in 2020
Figure 21. Global Pre-Menstrual Syndrome Revenue Market Share by Type (2016-2021)
Figure 22. Global Pre-Menstrual Syndrome Revenue Market Share by Type (2022-2027)
Figure 23. North America Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Pre-Menstrual Syndrome Market Share by Type (2016-2027)
Figure 25. North America Pre-Menstrual Syndrome Market Share by Application (2016-2027)
Figure 26. North America Pre-Menstrual Syndrome Market Share by Country (2016-2027)
Figure 27. United States Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Pre-Menstrual Syndrome Market Share by Type (2016-2027)
Figure 31. Europe Pre-Menstrual Syndrome Market Share by Application (2016-2027)
Figure 32. Europe Pre-Menstrual Syndrome Market Share by Country (2016-2027)
Figure 33. Germany Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Pre-Menstrual Syndrome Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Pre-Menstrual Syndrome Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Pre-Menstrual Syndrome Market Share by Region (2016-2027)
Figure 43. China Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Pre-Menstrual Syndrome Market Share by Type (2016-2027)
Figure 51. Latin America Pre-Menstrual Syndrome Market Share by Application (2016-2027)
Figure 52. Latin America Pre-Menstrual Syndrome Market Share by Country (2016-2027)
Figure 53. Mexico Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Pre-Menstrual Syndrome Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Pre-Menstrual Syndrome Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Pre-Menstrual Syndrome Market Share by Country (2016-2027)
Figure 59. Turkey Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Pre-Menstrual Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Alva-Amco Pharmacal Cos., Inc. Revenue Growth Rate in Pre-Menstrual Syndrome Business (2016-2021)
Figure 63. Bayer, Inc. Revenue Growth Rate in Pre-Menstrual Syndrome Business (2016-2021)
Figure 64. Chattem, Inc. (Sanofi) Revenue Growth Rate in Pre-Menstrual Syndrome Business (2016-2021)
Figure 65. DEKK-TEC, Inc. Revenue Growth Rate in Pre-Menstrual Syndrome Business (2016-2021)
Figure 66. G. R. Lane Health Products Ltd Revenue Growth Rate in Pre-Menstrual Syndrome Business (2016-2021)
Figure 67. McNeil Consumer Healthcare Revenue Growth Rate in Pre-Menstrual Syndrome Business (2016-2021)
Figure 68. MetP Pharma AG Revenue Growth Rate in Pre-Menstrual Syndrome Business (2016-2021)
Figure 69. Pherin Pharmaceuticals, Inc. Revenue Growth Rate in Pre-Menstrual Syndrome Business (2016-2021)
Figure 70. Umecrine Mood AB Revenue Growth Rate in Pre-Menstrual Syndrome Business (2016-2021)
Figure 71. Novartis AG Revenue Growth Rate in Pre-Menstrual Syndrome Business (2016-2021)
Figure 72. GlaxoSmithKline Plc Revenue Growth Rate in Pre-Menstrual Syndrome Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の多嚢胞性卵巣症候群（PCOS）治療薬市場規模・現状・予測（2021年-2027年） Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders among women of reproductive age. Market Analysis and Insights: Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market The global Polycystic Ovarian Syndrome (PCOS) Therapeutics market size is projected to reach …- 世界の経口避妊薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Contraceptive Pills Market The global Contraceptive Pills market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report mak…
- 月経カップのグローバル市場2021 Menstrual Cups is type of feminine hygiene product which is usually made of medical grade silicone, shaped like a bell and is flexible. It is worn inside the vagina during menstruation to catch menstrual fluid (blood), and can be worn during the day and overnight. Full Menstrual Cups are removed fro…
- 月経カップのグローバル市場2021 Menstrual Cups is type of feminine hygiene product which is usually made of medical grade silicone, shaped like a bell and is flexible. It is worn inside the vagina during menstruation to catch menstrual fluid (blood), and can be worn during the day and overnight. Full Menstrual Cups are removed fro…
- 多嚢胞性卵巣症候群（PCOS）治療法のグローバル市場：規模・現状・予測2019-2025 Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders among women of reproductive age. In 2018, the global Polycystic Ovarian Syndrome (PCOS) Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% durin…